Isotonitazepyne: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
 
Line 1: Line 1:
'''Isotonitazene''' is a potent synthetic [[opioid]] that is part of the [[benzimidazole]] class of opioids. It was first synthesized in the 1950s as part of a group of compounds known as the [[nitazenes]]. Isotonitazene is an analog of [[etazene]], which is itself an opioid analgesic.
{{DISPLAYTITLE:Isotonitazepyne}}


==Pharmacology==
== Overview ==
Isotonitazene is a [[mu-opioid receptor]] agonist. It is believed to have a potency approximately 500 to 600 times that of [[morphine]]. The drug's effects are primarily due to its action at the mu-opioid receptor, where it acts as a potent agonist. This results in profound analgesia, sedation, and respiratory depression, which can be life-threatening.
[[File:Isotonitazepyne_structure.png|thumb|right|Chemical structure of Isotonitazepyne]]
'''Isotonitazepyne''' is a synthetic opioid analgesic that belongs to the benzimidazole class of compounds. It is structurally related to other opioids such as [[etonitazene]] and is known for its potent analgesic properties. Isotonitazepyne has been the subject of research due to its potential use in pain management, but it also poses significant risks of abuse and addiction.


==Effects==
== Chemical Structure ==
The effects of isotonitazene are similar to other opioids and include pain relief, euphoria, sedation, and respiratory depression. However, due to its high potency, the risk of overdose and death is significantly higher than with other opioids. Symptoms of an overdose can include slow or stopped breathing, blue lips and skin, and unconsciousness.
Isotonitazepyne is characterized by its unique chemical structure, which includes a benzimidazole core. The presence of this core is a defining feature of the nitazene class of opioids. The chemical structure of Isotonitazepyne is depicted in the adjacent image, highlighting its complex arrangement of atoms that contribute to its pharmacological activity.


==Legal Status==
== Pharmacology ==
Isotonitazene is a controlled substance in many countries due to its high potential for abuse and addiction. In the United States, it is a Schedule I controlled substance, meaning it has no accepted medical use and a high potential for abuse.
Isotonitazepyne acts primarily as a [[mu-opioid receptor]] agonist, which is the primary mechanism through which it exerts its analgesic effects. By binding to these receptors, it mimics the action of endogenous opioids, leading to pain relief. However, this action also underlies its potential for abuse and the development of [[opioid use disorder]].


==See Also==
== Clinical Use ==
* [[Opioid epidemic]]
While Isotonitazepyne has been investigated for its potential in pain management, its clinical use is limited due to the high risk of addiction and overdose. It is not approved for medical use in many countries and is often encountered in the context of illicit drug use.
* [[Fentanyl]]
* [[Carfentanil]]


==References==
== Risks and Side Effects ==
<references />
The use of Isotonitazepyne carries significant risks, including respiratory depression, which can be fatal. Other side effects include nausea, vomiting, constipation, and sedation. The risk of overdose is particularly high, especially when used in combination with other central nervous system depressants such as [[benzodiazepines]] or [[alcohol]].
 
== Legal Status ==
Due to its potential for abuse and lack of approved medical use, Isotonitazepyne is classified as a controlled substance in many jurisdictions. It is important for healthcare providers and law enforcement to be aware of its presence in the illicit drug market.
 
== Related Pages ==
* [[Opioid]]
* [[Benzimidazole]]
* [[Etonitazene]]
* [[Opioid use disorder]]


[[Category:Opioids]]
[[Category:Opioids]]
[[Category:Synthetic opioids]]
[[Category:Synthetic drugs]]
[[Category:Drugs]]
[[Category:Controlled substances]]
[[Category:Pharmacology]]
 
{{pharmacology-stub}}

Latest revision as of 06:36, 16 February 2025


Overview[edit]

Chemical structure of Isotonitazepyne

Isotonitazepyne is a synthetic opioid analgesic that belongs to the benzimidazole class of compounds. It is structurally related to other opioids such as etonitazene and is known for its potent analgesic properties. Isotonitazepyne has been the subject of research due to its potential use in pain management, but it also poses significant risks of abuse and addiction.

Chemical Structure[edit]

Isotonitazepyne is characterized by its unique chemical structure, which includes a benzimidazole core. The presence of this core is a defining feature of the nitazene class of opioids. The chemical structure of Isotonitazepyne is depicted in the adjacent image, highlighting its complex arrangement of atoms that contribute to its pharmacological activity.

Pharmacology[edit]

Isotonitazepyne acts primarily as a mu-opioid receptor agonist, which is the primary mechanism through which it exerts its analgesic effects. By binding to these receptors, it mimics the action of endogenous opioids, leading to pain relief. However, this action also underlies its potential for abuse and the development of opioid use disorder.

Clinical Use[edit]

While Isotonitazepyne has been investigated for its potential in pain management, its clinical use is limited due to the high risk of addiction and overdose. It is not approved for medical use in many countries and is often encountered in the context of illicit drug use.

Risks and Side Effects[edit]

The use of Isotonitazepyne carries significant risks, including respiratory depression, which can be fatal. Other side effects include nausea, vomiting, constipation, and sedation. The risk of overdose is particularly high, especially when used in combination with other central nervous system depressants such as benzodiazepines or alcohol.

Legal Status[edit]

Due to its potential for abuse and lack of approved medical use, Isotonitazepyne is classified as a controlled substance in many jurisdictions. It is important for healthcare providers and law enforcement to be aware of its presence in the illicit drug market.

Related Pages[edit]